AR004429A1 - PHARMACEUTICAL FORMULA COMPRISING BERCEDIN, POSOLOGICAL FORM UNDERSTANDING IT, METHOD TO PRODUCE BERCEDIN, CANA DE SUGAR EXTRACT OBTAINED IN THE METHOD AND PHARMACEUTICAL COMPOSITION WHICH INCLUDES SUCH EXTRACT. - Google Patents

PHARMACEUTICAL FORMULA COMPRISING BERCEDIN, POSOLOGICAL FORM UNDERSTANDING IT, METHOD TO PRODUCE BERCEDIN, CANA DE SUGAR EXTRACT OBTAINED IN THE METHOD AND PHARMACEUTICAL COMPOSITION WHICH INCLUDES SUCH EXTRACT.

Info

Publication number
AR004429A1
AR004429A1 ARP970103168A ARP970103168A AR004429A1 AR 004429 A1 AR004429 A1 AR 004429A1 AR P970103168 A ARP970103168 A AR P970103168A AR P970103168 A ARP970103168 A AR P970103168A AR 004429 A1 AR004429 A1 AR 004429A1
Authority
AR
Argentina
Prior art keywords
bercedin
extract
pharmaceutical
pharmaceutical composition
posological
Prior art date
Application number
ARP970103168A
Other languages
Spanish (es)
Original Assignee
Biocell Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocell Res Inc filed Critical Biocell Res Inc
Publication of AR004429A1 publication Critical patent/AR004429A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C07H1/08—Separation; Purification from natural products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La presente invención se relaciona con fórmula farmacéutica que comprende bercedin, forma posológica que la comprende, método para producir bercedin,extracto de cana de azúcar obtenido en el método y composición farmacéutica que comprende dichoext racto donde las composiciones terapéuticas son derivadasde la cana de azúcar, y son útiles para el tratamiento de una variedad de afecciones patológicas en animales, particularmente el ser humano, incluyendolas causadas por inflamación,infecci ón bacteriana, virósica o micótica, toxinas; traumatismos tales como quemaduras y otros.The present invention relates to a pharmaceutical formula comprising bercedin, a dosage form comprising it, a method for producing bercedin, an extract of sugar cane obtained in the method and a pharmaceutical composition comprising said end section where the therapeutic compositions are derived from sugar cane, and they are useful for the treatment of a variety of pathological conditions in animals, particularly humans, including those caused by inflammation, bacterial, viral or fungal infection, toxins; trauma such as burns and others.

ARP970103168A 1996-07-17 1997-07-15 PHARMACEUTICAL FORMULA COMPRISING BERCEDIN, POSOLOGICAL FORM UNDERSTANDING IT, METHOD TO PRODUCE BERCEDIN, CANA DE SUGAR EXTRACT OBTAINED IN THE METHOD AND PHARMACEUTICAL COMPOSITION WHICH INCLUDES SUCH EXTRACT. AR004429A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2187596P 1996-07-17 1996-07-17

Publications (1)

Publication Number Publication Date
AR004429A1 true AR004429A1 (en) 1998-12-16

Family

ID=21806627

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970103168A AR004429A1 (en) 1996-07-17 1997-07-15 PHARMACEUTICAL FORMULA COMPRISING BERCEDIN, POSOLOGICAL FORM UNDERSTANDING IT, METHOD TO PRODUCE BERCEDIN, CANA DE SUGAR EXTRACT OBTAINED IN THE METHOD AND PHARMACEUTICAL COMPOSITION WHICH INCLUDES SUCH EXTRACT.

Country Status (5)

Country Link
EP (1) EP0880318A4 (en)
AR (1) AR004429A1 (en)
AU (1) AU3901297A (en)
CA (1) CA2232297A1 (en)
WO (1) WO1998002041A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69942420D1 (en) * 1998-10-09 2010-07-08 Mitsui Sugar Co PREVENTIVA / MEANS OF INFECTION, ANTI-ENDOTOXIN AGENTS, VACCINATE ADJUVANTS AND GROWTH PROMOTERS
AU2359800A (en) * 1998-12-14 2000-07-03 Biocell Research, Inc. Methods for improving growth and for reducing bacterial colonization of poultry
JP5002097B2 (en) * 2001-08-28 2012-08-15 独立行政法人農業・食品産業技術総合研究機構 Preventive / therapeutic agent for human or animal disease caused by coccidium and adjuvant agent for immunization of human or animal against mild coccidium infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
DE4138192A1 (en) * 1990-08-30 1993-05-27 Karin Omlor Topical medicament comprising microbial culture - in decoction of sugar-cane juice and green tea
US5547674A (en) * 1995-04-14 1996-08-20 University Of Southern California Pharmaceutical preparations derived from European mistletoe

Also Published As

Publication number Publication date
EP0880318A4 (en) 1999-07-28
AU3901297A (en) 1998-02-09
EP0880318A1 (en) 1998-12-02
CA2232297A1 (en) 1998-01-22
WO1998002041A1 (en) 1998-01-22

Similar Documents

Publication Publication Date Title
WO2003032994A3 (en) Novel tri-substituted pyrimidines, method for production and use thereof as medicament
WO2002014311A3 (en) Urea compounds and methods of uses
EA200701296A1 (en) 3,5-Disposable and 3,5,7-triple-substituted 3H-oxazolo-and 3H-thiazolo [4,5-D] pyrimidin-2-she and their medicines
MXPA05011208A (en) Topical formulation of ivermectin for the treatment of dermatological conditions.
DE69838070D1 (en) SUBSTITUTED PYRIDINE DERIVATIVES AS ANTI-INFLAMMATORY AGENTS
PL371428A1 (en) Substituted indolizine-like compounds and methods of use
TW200626608A (en) Macrolides
BR0214705A (en) Composition, use, method for prevention or treatment of neurodegenerative disease, and kit
WO2004041203A3 (en) Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
BRPI0410306A (en) methods for treating, controlling or preventing a specific cancer, treating, controlling or preventing a disease associated with unwanted angiogenesis, and for reducing or preventing an adverse effect, pharmaceutical composition, and kit.
CY1105407T1 (en) ALDONIC ACIDS OF OLIGOSACCHARITES AND THEIR TOPICAL USE
IS8175A (en) Piperazine derivatives and methods of their use
BR0114785A (en) Adjuvant composition, vaccine composition, and, methods for diverting, the quality of an immune response against an antigen, for the manufacture of a vaccine composition, and for treating an individual susceptible to or suffering from a disease.
ATE372764T1 (en) ANTIPRURITIC COMPOSITIONS AND COMPOSITIONS PROMOTING WOUND HEALING
BR0214962A (en) Composition for treating neurocerebrovascular disorders
WO2006029081A3 (en) Nucleoside-lipid conjugates, their method of preparation and uses thereof
WO2005034883A3 (en) A method of healing skin wounds in mammals and a composition therefor
HUP0101710A2 (en) Matrix protein compositions for wound healing
BR0015698A (en) Compositions and methods for treating allergic diseases
RU95103892A (en) COMPOSITION FOR TOPIC APPLICATION FOR HAIR GROWTH STIMULATION AND/OR THEIR FALLING OUT RETARDATION, METHOD OF COSMETIC HAIR TREATMENT, USE OF α-PYRONE DERIVATIVE FOR COMPOSITION PREPARING
FR2768622B1 (en) Rosacea extract as antagonist of bradykinin
BR0109036A (en) Pharmaceutical Formulations
MA27059A1 (en) AZITHROMYCIN IN SINGLE DOSE
EP0734725A3 (en) Adjuvants containing colloidal iron compounds
AR004429A1 (en) PHARMACEUTICAL FORMULA COMPRISING BERCEDIN, POSOLOGICAL FORM UNDERSTANDING IT, METHOD TO PRODUCE BERCEDIN, CANA DE SUGAR EXTRACT OBTAINED IN THE METHOD AND PHARMACEUTICAL COMPOSITION WHICH INCLUDES SUCH EXTRACT.

Legal Events

Date Code Title Description
FB Suspension of granting procedure